JP3529392B2 - Insertion medicine - Google Patents

Description

Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the treatment of hemorrhoids, enteric diseases and other diseases, fever relief, analgesia, etc.
On interpolation Nyukusuri to be inserted road or et al. [0002] Conventionally, hemorrhoids, treatment of intestinal diseases and other diseases, fever, for the purpose of pain relief, etc., anus, vagina, interpolation to insert the urinary tract or we Nyukusuri is frequently used. Such inserts are generally shell-shaped and solid. In order to use an insertion drug having such a shape, the insertion is performed by inserting the front end of the insertion drug into the body from the anus or the like. It stays in the body due to friction with the inner wall such as the intestine. [0003] However, in the case of a solid suppository, the suppository adheres to the inner wall of the intestine and obstructs the intestine. Therefore, when exhausting intestinal gas (so-called fart) from the anus, There has been a problem that the suppository is also discharged from the anus simultaneously with intestinal gas. When inserting a suppository into the vagina, in addition to the above problems, there is also a problem that the suppository cannot be inserted into the vagina during menstruation. In addition, a suppository inserted into the urethra has a problem that it is not possible to urinate until the suppository is dissolved. The present invention has been made in view of the斯Ru problems, and its object, even when using the suppository other insertion drugs, to discharge only Chonaiga scan the body, adding the urination Another object of the present invention is to provide an insertion drug that can be used at the time of menstruation as well as at the time of menstruation. [0004] SUMMARY OF THE INVENTION the SUMMARY OF THE INVENTION The first aspect, anus, vagina, a interpolation Nyukusuri to insert the urinary tract or al, insertion drugs even least <br/> without Having a flow portion penetrating in the insertion direction, the flow portion is formed by a cylindrical flow portion forming material having a hole penetrating at least in the longitudinal direction, the flow portion forming material,
The present invention relates to an insertion drug characterized by being composed of a slow-dissolving substance having a dissolution rate lower than that of a suppository body. [0005] [action] distribution unit through the intestinal gas. An embodiment of the present invention will be described below in detail with reference to the drawings. However, the dimensions, materials, shapes, relative arrangements, and the like of the components described in the present embodiment are not intended to limit the scope of the present invention only to them unless otherwise specified. , Are merely illustrative examples. (Embodiment 1) First, Embodiment 1 according to the present invention.
Will be described with reference to FIGS. 1 to 5. This suppository 1
Reference numeral 0 denotes a flow portion (indicated by a dotted line in FIG. 1) 1 which has a substantially shell shape as shown in FIGS.
One. More specifically, a maximum diameter portion 13 having the largest diameter is formed at about 1/5 from the front end 12, and the diameter gradually increases from the front end 12 toward the maximum diameter portion 13. The diameter gradually decreases toward the rear end 14. The front end 12 is slightly cut by a plane perpendicular to the longitudinal direction, and the rear end 14 is substantially flat parallel to the plane. The flow portion 11 has a cylindrical shape having the same diameter in all cross sections concentric with the center of the outer diameter and orthogonal to the longitudinal direction. Such an inner diameter may be determined in consideration of the dissolution time of the suppository 10 itself. In order to form such a flow portion 11, a bullet-shaped suppository may be formed and then a central portion thereof may be perforated after molding, or may be formed using a mold capable of forming the flow portion 11. Such a suppository 10 can be used in the same manner as in the conventional method. Since the suppository 10 according to the first embodiment is configured as described above, the circulation part 11 communicates before and after the suppository 10 even when inserted into the intestine or vagina. Therefore, it is possible to suppositories 10 even if a so-called fart like together without being discharged intestinal gas from the anus or the like, to discharge only intestinal gas. It can also be used during menstruation. Further, even when the suppository 10 is inserted into the urethra, it is possible to add a small business. These effects are particularly large when the suppository 10 is a slowly dissolving substance that maintains its shape over a long period of time by gradually dissolving. In such a case, the medicinal effect can be maintained for a long time. In the first embodiment, the shape is as described above, but this is not intended to limit the scope of the present invention. In the present invention, another shape, for example, a shape in which a plurality of flow portions 15 are formed as shown in FIG. It may be. Further, as shown in FIG. 5, the cross section may be substantially C-shaped. According to such a configuration, the cross-sectional area of the flow portion 16 can be increased as compared with the case where the outer diameter and the inner diameter are equal. In FIGS.
0 'and 10 "are suppositories. Further, the outer diameter of the suppository 10 may be larger than that of a normal insertion drug in order to maintain the suppository 10 for a long time. It is also applicable to all insertions, and does not select the outer contour of the suppository, nor should it be used in the future if ear or nose insertions are developed. The present invention can be applied to the present invention, wherein an insertion drug having a distribution section is audible when inserted into the ear, and nasal breathing is enabled when inserted into the nose. Next, the shape of the suppository according to Example 2 will be described.
1 and a cylindrical body (flow section forming material) 2 forming the flow section 22
3 The shapes of the suppository body 21 and the distribution part 22 are the same as those of the first embodiment. As shown in FIGS. 6 to 8, the cylindrical body 23 has the same length as the suppository body 21, and has the same outer diameter and inner diameter in each cross section, and has a slower dissolution rate than the suppository body 21. It is composed of In order to manufacture such a suppository 20, the center of the shell-shaped suppository 20 is pierced, and then a separately manufactured cylindrical body 23 is formed.
May be performed by a suitable method such as fitting. According to suppositories 20 thus configured than the flow section 22 in Example 1 above, it is possible to maintain a longer period of time, it can be discharged only long intestinal gas. Example 2
In the above, the cylindrical body 23 is the same length as the suppository main body 21, but can be longer than the suppository main body 21. In such a case, even when the suppository main body 21 is dissolved, it is possible to prevent the circulation part 22 from being blocked by the dissolved medicine due to the body temperature. Further, as shown in FIG. 9, if the cylindrical body 24 has a substantially C-shaped cross section, it can be applied to a suppository body 25 having a substantially C-shaped cross section.
In the figure, reference numeral 20 'denotes a suppository, and 26 denotes a distribution unit. Also,
In the second embodiment, the cylindrical body 23 is made of a slow-soluble substance, but may be made of an insoluble substance that is not dissolved by body temperature. In such a case, the cylindrical body remains without being dissolved even after the suppository body 21 is dissolved in the body, and is discharged outside the body at the time of defecation. (Embodiment 3) Next, the shape of the suppository according to Embodiment 3 will be described. As shown in FIG. 11, the suppository 30 is generally in a shell shape but has a flow groove 31 on the outer peripheral surface. As shown in FIG. 12, the flow groove 31 has a shape of about 1/6 circle in a cross-sectional view, and is continuous in the longitudinal direction of the suppository 30. The flow groove 31 forms a gap through which gas passes between the inner wall of the intestine or the like and the outer peripheral surface of the suppository 30. Therefore, even in such a suppository 30, intestinal gas
Nest only can be discharged to the outside of the body. The shape and number of the flow grooves may be as shown in FIG. Further, as shown in FIG. In the figure, reference numerals 32 and 34 denote suppositories, and reference numerals 33 and 35 denote flow grooves. Fourth Embodiment A suppository 40 according to a fourth embodiment has the same shape as that of each of the above-described embodiments, but as shown in FIG. Intestinal movement) and the length t of the nodes n and n are the same. In such a case, fart discharge can be performed more effectively than in the above embodiments. If the lid is much shorter than the interval between nodes n and n, the suppository will be generally between nodes n and n, and in such a case, from one node n to the node n preceding the anal direction. While it is difficult to fart, if the length of the suppository 40 is set to be the same as the interval between the nodes n in the peristalsis as described above, the suppository 40 becomes the nodes n and n
This is because the circulating portion 41 that always straddles between the two will always communicate the belly a of the peristaltic movement with the belly a. The present invention is configured as described above, and has the following effects. Since circulation of the insertion agents according to the present invention through the intestinal gas can also be the Tokoroihe discharging only the gas. It can also be inserted into the vagina during menstruation. Also, when a suppository is inserted into the urethra, small doses can be added. Further, since the length of the circulation part is longer than the interval between nodes in the peristaltic movement of the intestine for digestive action, intestinal gas can be effectively discharged. As a result, according to the present invention, the insertion drug can be used more comfortably as compared with the prior art.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a side view of a suppository according to Example 1. FIG. 2 is a front view of the suppository. FIG. 3 is a rear view of the suppository. FIG. 4 is a cross-sectional view of a maximum diameter portion showing a modification of the suppository. FIG. 5 is a cross-sectional view of a maximum diameter portion showing another modification of the suppository. FIG. 6 is a side view of a suppository according to Example 2. FIG. 7 is a front view of the suppository. FIG. 8 is a rear view of the suppository. FIG. 9 is a cross-sectional view of a maximum diameter portion showing a modification of the suppository. FIG. 10 is a side view of a suppository according to Example 3. FIG. 11 is a cross-sectional view of the maximum diameter portion of the suppository. FIG. 12 is a cross-sectional view of a maximum diameter portion showing a modification of the suppository. FIG. 13 is a cross-sectional view of a maximum diameter portion showing another modification of the suppository. FIG. 14 is a side view showing another modified example of the suppository. [Description of Signs] 10, 10 ', 10 ", 20, 20', 30, 32, 3
4, 40 Suppositories 11, 22, 26, 41 Distribution part 23 Distribution part forming material 31, 33, 35 Distribution groove I Intestine n node a belly

Claims (1)

(57) [Claims 1] anal, vaginal, an interpolation Nyukusuri to insert the urinary tract or al, has a flow section that penetrates the insertion direction of the insertion drug even without small, the The flow portion is formed of a cylindrical flow portion forming material having a hole penetrating at least in the longitudinal direction, and the flow portion forming material is formed of a slow-soluble substance having a lower dissolution rate than the suppository body. And insert drugs.